TrialBlood2025

Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG ReLApsE trial.

Marc-Andrea Baertsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.